Taken together, our findings suggest that IGFBP7 plays an important tumor-suppressive role in human thyroid cancer, especially in FTC and ATC subtypes and may represent a promising biomarker and therapeutic target for the disease. This evidence concerns the gene IGFBP7 and thyroid gland carcinoma.